NEUMORA THERAPEUTICS, INC. Common Stock, Value, Issued
NEUMORA THERAPEUTICS, INC. (NMRA) had Common Stock, Value, Issued of $19.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-14
- 2026-06-30: Common Stock, Value, Issued $19.00K.
- 2026-03-31: Common Stock, Value, Issued $18.00K.
- 2025-12-31: Common Stock, Value, Issued $17.00K.
- 2025-09-30: Common Stock, Value, Issued $16.00K.
| Period end | Common Stock, Value, Issued |
|---|---|
| 2026-06-30 | $19.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $18.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $17.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $16.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $16.00K 10-Q · filed 2025-08-06 |
| 2025-03-31 | $16.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $16.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $16.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $16.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $16.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $16.00K 10-K · filed 2025-03-03 |
| 2023-09-30 | $15.00K 10-Q · filed 2023-11-01 |
| 2022-12-31 | $3.00K 10-K · filed 2024-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |